Safety and Effectiveness of Micardis [telmisartan] Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertension Patients.
Phase of Trial: Phase IV
Latest Information Update: 03 Jun 2014
At a glance
- Drugs Telmisartan (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 19 Feb 2010 Actual number of patients changed from 3002 to 3148 as reported by ClinicalTrials.gov.
- 29 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jan 2009 Planned number of patients changed from 3000 to 3002 as reported by ClinicalTrials.gov.